Today is the day! Patients, families, doctors and researchers including Dr. Bedlack will testify to the FDA in support of approval for the drug AMX0035.
Translating Research Into Treatment Approaches for ALS Dr. Bedlack presented a talk at Brainweek entitled A Shifting Paradigm: Translating Research Into Treatment Approaches for ALS